The Pennant Group (NASDAQ:PNTG) Stock Rating Upgraded by Wall Street Zen

The Pennant Group (NASDAQ:PNTG) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Monday.

PNTG has been the subject of a number of other reports. Zacks Research upgraded shares of The Pennant Group from a “hold” rating to a “strong-buy” rating in a report on Thursday. Royal Bank Of Canada upped their price target on The Pennant Group from $34.00 to $39.00 and gave the company an “outperform” rating in a report on Monday, November 17th. Stephens reiterated an “overweight” rating and issued a $40.00 price objective on shares of The Pennant Group in a report on Thursday, October 9th. Weiss Ratings restated a “hold (c)” rating on shares of The Pennant Group in a research note on Monday, November 17th. Finally, Wells Fargo & Company upgraded shares of The Pennant Group from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $29.00 to $31.00 in a research note on Tuesday, November 18th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $33.60.

The Pennant Group Price Performance

Shares of NASDAQ:PNTG opened at $26.67 on Monday. The business has a fifty day moving average price of $24.95 and a 200-day moving average price of $25.78. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The company has a market capitalization of $922.52 million, a PE ratio of 35.56, a PEG ratio of 2.16 and a beta of 1.39. The Pennant Group has a 1-year low of $21.18 and a 1-year high of $32.00.

The Pennant Group (NASDAQ:PNTG) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.29 by $0.01. The company had revenue of $229.04 million for the quarter, compared to the consensus estimate of $221.96 million. The Pennant Group had a net margin of 3.15% and a return on equity of 9.37%. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. As a group, equities analysts expect that The Pennant Group will post 0.75 EPS for the current fiscal year.

Hedge Funds Weigh In On The Pennant Group

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Versor Investments LP grew its position in The Pennant Group by 6.2% during the first quarter. Versor Investments LP now owns 12,000 shares of the company’s stock valued at $302,000 after buying an additional 700 shares during the period. Quantum Portfolio Management LLC raised its holdings in The Pennant Group by 4.7% in the 2nd quarter. Quantum Portfolio Management LLC now owns 16,049 shares of the company’s stock worth $479,000 after purchasing an additional 721 shares during the period. Intech Investment Management LLC lifted its position in The Pennant Group by 4.8% during the second quarter. Intech Investment Management LLC now owns 17,800 shares of the company’s stock valued at $531,000 after purchasing an additional 822 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in The Pennant Group by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,394 shares of the company’s stock valued at $488,000 after purchasing an additional 857 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey increased its position in The Pennant Group by 13.7% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 7,922 shares of the company’s stock worth $236,000 after buying an additional 953 shares in the last quarter. Hedge funds and other institutional investors own 85.88% of the company’s stock.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.